Hepatitis E Virus Infection as a Possible Cause of Acute Liver Failure in Europe

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 10, 2015, Pages 1836-1842.e2

  Manka, Paul ^a   Bechmann, Lars P ^a   Coombes, Jason D ^b   Thodou, Viktoria ^a   Schlattjan, Martin ^a   Kahraman, Alisan ^a   Syn, Wing Kin ^b,c   Saner, Fuat ^a   Gerken, Guido ^a   Baba, Hideo ^a   Verheyen, Jens ^a   Timm, Jörg ^d   Canbay, Ali ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b INSTITUTE OF HEPATOLOGY   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Blood Test; Diagnosis; Hepatitis E; Liver Disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA; HEPATITIS ANTIBODY;

ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; GERMANY; HEPATITIS E; HUMAN; IMMUNOBLOTTING; IMMUNOCOMPETENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SERODIAGNOSIS; VIRUS LOAD; BLOOD; COMPLICATION; GENETICS; HEPATITIS E VIRUS; IMMUNOLOGY; LIVER FAILURE, ACUTE; MIDDLE AGED; PREVALENCE;

ADULT; EUROPE; FEMALE; GERMANY; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 84941744987     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.04.014     Document Type: Article

References (35)

1. Bernal W., Wendon J. Acute liver failure. N Engl J Med 2013, 369:2525-2534.
2. Faber M.S., Wenzel J.J., Jilg W., et al. Hepatitis E virus seroprevalence among adults. Germany. Emerg Infect Dis 2012, 18:1654-1657.
3. Pavio N., Mansuy J.M. Hepatitis E in high-income countries. Curr Opin Infect Dis 2010, 23:521-527.
4. Wenzel J.J., Preiss J., Schemmerer M., et al. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013, 207:497-500.
5. Dalton H.R., Bendall R., Ijaz S., et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
6. Lewis H.C., Wichmann O., Duizer E. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 2010, 138:145-166.
7. Parkash O., Mumtaz K., Hamid S., et al. MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure. J Coll Physicians Surg Pak 2012, 22:492-496.
8. Acharya S.K., Panda S.K., Saxena A., et al. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol 2000, 15:473-479.
9. Fontana R.J., Engle R.E., Trivedi S., et al. The role of hepatitis E virus infection in adult American patients with acute liver failure. Hepatology 2012, 56:958A-959A.
10. Kuniholm M.H., Purcell R.H., McQuillan G.M., et al. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009, 200:48-56.
11. Hadem J., Tacke F., Bruns T., et al. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol 2012, 10:664-669.e2.
12. Crossan C.L., Simpson K.J., Craig D.G., et al. Hepatitis E virus in patients with acute severe liver injury. World J Hepatol 2014, 6:426-434.
13. Wenzel J.J., Preiss J., Schemmerer M., et al. Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol 2011, 52:50-54.
14. Baylis S.A., Blümel J., Mizusawa S., et al. World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013, 19:729-735.
15. Bernal W., Hyyrylainen A., Gera A., et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013, 59:74-80.
16. Dalton H.R., Kamar N., Izopet J. Hepatitis E in developed countries: current status and future perspectives. Future Microbiol 2014, 9:1361-1372.
17. Koot H., Hogema B.M., Koot M., et al. Frequent hepatitis E in the Netherlands without traveling or immunosuppression. J Clin Virol 2015, 62:38-40.
18. Davern T.J., Chalasani N., Fontana R.J., et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011, 141:1665-1672. e1-9.
19. Chen E.Y., Baum K., Collins W., et al. Hepatitis E masquerading as drug-induced liver injury. Hepatology 2012, 56:2420-2423.
20. Rockey D.C., Seeff L.B., Rochon J., et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010, 51:2117-2126.
21. Dalton H.R., Fellows H.J., Stableforth W., et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007, 26:1429-1435.
22. Pischke S., Gisa A., Suneetha P.V., et al. Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS One 2014, 9:e85330.
23. Vieira C.L., Baldaia C., Fatela N., et al. Case of acute hepatitis E with concomitant signs of autoimmunity. World J Hepatol 2013, 5:152-155.
24. Sebode M., Pischke S., Lütgehetmann M., et al. New foe treated with old guns - supportive role of steroids in the treatment of acute severe hepatitis E. BMC Gastroenterol 2014, 14:191.
25. Drobeniuc J., Meng J., Reuter G., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
26. Pischke S., Suneetha P.V., Baechlein C., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transplant 2010, 16:74-82.
27. Hoofnagle J.H., Nelson K.E., Purcell R.H. Hepatitis E. N Engl J Med 2012, 367:1237-1244.
28. Stoszek S.K., Engle R.E., Abdel-Hamid M., et al. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg 2006, 100:89-94.
29. Ramachandran J., Eapen C.E., Kang G., et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004, 19:134-138.
30. Höner zu Siederdissen C., Pischke S., Schlue J., et al. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology 2014, 60:1112-1113.
31. Koenecke C., Pischke S., Heim A., et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?. Transpl Infect Dis 2012, 14:103-106.
32. Abravanel F., Mansuy J.-M., Huynh A., et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012, 54:152-155.
33. Van der Eijk A.A., Pas S.D., Cornelissen J.J., et al. Hepatitis E virus infection in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis 2014, 27:309-315.
34. Doudier B., Vencatassin H., Aherfi S., et al. Fatal fulminant hepatitis E associated with autoimmune hepatitis and excessive paracetamol intake in Southeastern France. J Clin Microbiol 2014, 52:1294-1297.
35. Escudié L., Francoz C., Vinel J.-P., et al. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 2007, 46:466-473.